Drugs / PF-03526299
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01299467 | Feb 2011 → Feb 2012 | asthma | Pfizer | Withdrawn | No outcome recorded |
| Phase 1 | NCT00990756 | Nov 2009 → Jan 2010 | — | Pfizer | Completed | No outcome recorded |
| Phase 1 | NCT00877539 | Jun → Dec 2009 | asthma | Pfizer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-03526299 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00990756 ↗ |
| Route | Inhaled | “Inhaled, two doses 4 hours apart” NCT00877539 ↗ |